| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
109 |
| issn |
2233-7385
2233-7393 |
| issueIdentifier |
2 |
| pageRange |
103-109 |
| publicationName |
Chonnam Medical Journal |
| startingPage |
103 |
| bibliographicCitation |
Kwon YS. Clinical Implications of New Drugs and Regimens for the Treatment of Drug-resistant Tuberculosis. Chonnam Med J. 2017 May;53(2):103–9. PMID: 28584788; PMCID: PMC5457944. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05fe54ea7a195d18c4b981a55ed2befc |
| date |
201705 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC5457944
https://doi.org/10.4068/cmj.2017.53.2.103
https://pubmed.ncbi.nlm.nih.gov/28584788 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39667
https://portal.issn.org/resource/ISSN/2233-7393
https://portal.issn.org/resource/ISSN/2233-7385 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Clinical Implications of New Drugs and Regimens for the Treatment of Drug-resistant Tuberculosis |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388906
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID456199
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6480466
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8355 |